These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15148978)

  • 21. The safety of spironolactone treatment in patients with heart failure.
    Anton C; Cox AR; Watson RD; Ferner RE
    J Clin Pharm Ther; 2003 Aug; 28(4):285-7. PubMed ID: 12911680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ineffective atrial pacing and cardiac arrest in a 80-year old woman with hyperkalemia].
    Lelakowski J; Czunko A; Majewski J; Pasowicz M; Małecka B; Bednarek J
    Pol Merkur Lekarski; 2005 May; 18(107):566-7. PubMed ID: 16161957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elderly heart failure patients with drug-induced serious hyperkalemia.
    Vanpee D; Swine CH
    Aging (Milano); 2000 Aug; 12(4):315-9. PubMed ID: 11073352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spironolactone in patients with heart failure.
    Vanpee D; Swine C
    N Engl J Med; 2000 Jan; 342(2):133; author reply 133-4. PubMed ID: 10636753
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperkalaemia in the age of aldosterone antagonism.
    Chapagain A; Ashman N
    QJM; 2012 Nov; 105(11):1049-57. PubMed ID: 22723454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The 10-minute consultation. Accidental finding: hyperkalemia. Caution with analgesics and bananas].
    Lenz T
    MMW Fortschr Med; 2005 Jan; 147(4):59-60. PubMed ID: 15745346
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES).
    Hauben M; Reich L; Gerrits CM; Madigan D
    Drug Saf; 2007; 30(12):1143-9. PubMed ID: 18035866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction.
    Ray K; Dorman S; Watson R
    J Hum Hypertens; 1999 Oct; 13(10):717-20. PubMed ID: 10516744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined use of an ACE-inhibitor and spironolactone in patients with heart insufficiency.
    Schröder J; Goltz L; Knoth H
    Med Monatsschr Pharm; 2017 Jan; 40(1):24-6. PubMed ID: 29952529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renal effect of treatment for heart failure].
    Rasmussen ZZ; Barfod T; Klit J
    Ugeskr Laeger; 2009 Feb; 171(9):718. PubMed ID: 19257999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice.
    Michel A; Martín-Pérez M; Ruigómez A; García Rodríguez LA
    Eur J Heart Fail; 2015 Feb; 17(2):205-13. PubMed ID: 25581138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spironolactone in patients with heart failure.
    Larkin RJ; Atlas SA; Donohue TJ
    N Engl J Med; 2000 Jan; 342(2):132-3; author reply 133-4. PubMed ID: 10636751
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperkalemia in ambulant postcardiac surgery patients during combined therapy with angiotensin-converting enzyme inhibitor, spironolactone, and diet rich in potassium: A report of two cases and review of literature.
    Dixit A; Majumdar G; Tewari P
    Ann Card Anaesth; 2019; 22(2):162-168. PubMed ID: 30971598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life threatening hyperkalaemia with diarrhoea during ACE inhibition.
    McGuigan J; Robertson S; Isles C
    Emerg Med J; 2005 Feb; 22(2):154-5. PubMed ID: 15662077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Junctional escape rhythm secondary to acute hyperkalemic renal failure in the setting of concurrent beta-blocker therapy.
    Isabel J; Champion JC
    JAAPA; 2006 Dec; 19(12):78. PubMed ID: 17243264
    [No Abstract]   [Full Text] [Related]  

  • 37. [Spironolactone and potassium].
    Kjeldsen K
    Ugeskr Laeger; 2004 Nov; 166(48):4392; author reply 4392-3. PubMed ID: 15587639
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Bugge JF
    J Intern Med; 1996 Oct; 240(4):249-51. PubMed ID: 8918517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases].
    Svensson M; Gustafsson F; Galatius S; Hildebrandt PR; Atar D
    Ugeskr Laeger; 2004 Sep; 166(37):3201-3. PubMed ID: 15384373
    [No Abstract]   [Full Text] [Related]  

  • 40. Severe hyperkalaemia with prescription of potassium-retaining agents in an elderly patient.
    Martin J; Mourton S; Nicholls G
    N Z Med J; 2003 Aug; 116(1179):U542. PubMed ID: 14513088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.